Ocular Anti-Vegf Therapy for Diabetic Retinopathy: Overview of Clinical Efficacy and Evolving Applications

Diabetes Care - United States
doi 10.2337/dc13-1990
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Ocular Anti-Vegf Therapy for Diabetic Retinopathy: The Role of VEGF in the Pathogenesis of Diabetic Retinopathy

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2014English

Optical Coherence Tomography Use for Estimation of the Efficacy of Anti VEGF Therapy in Diabetic Retinopathy and Diabetic Macular Edema.

The Professional Medical Journal
2019English

Laser or Anti‐VEGF for Proliferative Diabetic Retinopathy

Acta Ophthalmologica
MedicineOphthalmology
2018English

Diabetic Retinopathy and VEGF

Open Ophthalmology Journal
Ophthalmology
2013English

The Evolving Treatment of Diabetic Retinopathy

Clinical Ophthalmology
Ophthalmology
2020English

Ocular Associations of Diabetes Other Than Diabetic Retinopathy

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2008English

Anti Diabetic Plants-Overview

Current Research in Diabetes & Obesity Journal
2018English

Ocular Autonomic Nerve Function in Proliferative Diabetic Retinopathy

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
1988English

Predicting Efficacy and Toxicity in the Era of Targeted Therapy: Focus on Anti-Egfr and Anti-Vegf Molecules

Current Drug Metabolism
Clinical BiochemistryPharmacology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy